Salivary Gland Tumors: Diagnostic Value of Gadolinium-enhanced Dynamic MR Imaging with Histopathologic Correlation
Authors
Affiliations
Purpose: To evaluate the diagnostic value of gadolinium-enhanced dynamic magnetic resonance (MR) imaging of salivary gland tumors and correlate the MR imaging and histopathologic findings.
Materials And Methods: Thirty-three salivary gland tumors in 29 patients were examined preoperatively at gadolinium-enhanced dynamic MR imaging. There were 22 benign and 11 malignant tumors. Dynamic contrast material-enhanced MR images were obtained for 5 minutes. Time of peak enhancement (T(peak)) and washout ratio (WR) were determined from time-signal intensity curves (TICs). Microvessel count and cellularity-stromal grade were evaluated histopathologically. The strengths of correlations between T(peak) and microvessel count and between WR and cellularity-stromal grade were statistically analyzed. Statistical analysis was also performed to determine whether any differences among the various histopathologic tumor types existed [corrected]. In a validation study, 13 salivary gland tumors in 13 patients were examined consecutively.
Results: At a T(peak) of 120 seconds, malignant tumors could be differentiated from pleomorphic adenomas but not from Warthin tumors. A WR of 30%, however, enabled differentiation between malignant and Warthin tumors. Classification of TICs on the basis of a T(peak) of 120 seconds and a WR of 30% had high sensitivity (91%) and specificity (91%) in the differentiation of benign and malignant tumors. Correlations between T(peak) and microvessel count (P <.0001, rho = -0.800) and between WR and cellularity-stromal grade (P =.0105, rho = 0.572) were significant. The validation study also yielded high sensitivity (100%) and specificity (80%) in the differentiation between benign and malignant tumors.
Conclusion: Gadolinium-enhanced dynamic MR imaging is useful for differentiating benign from malignant salivary gland tumors.
High Field MRI in Parotid Gland Tumors: A Diagnostic Algorithm.
Gaudino C, Cassoni A, Pisciotti M, Pucci R, Veneroso C, Di Gioia C Cancers (Basel). 2025; 17(1.
PMID: 39796701 PMC: 11719534. DOI: 10.3390/cancers17010071.
Hu H, Pu X, Zhou J, Jiang W, Wu Q, Lu J Korean J Radiol. 2024; 25(12):1070-1082.
PMID: 39543863 PMC: 11604342. DOI: 10.3348/kjr.2024.0335.
MRI and CT imaging characteristics in parotid tumors with false-negative fine-needle aspirations.
Jee Lee H, Kang H, Lee J, Lee M, Kim S, Lee Y Head Face Med. 2024; 20(1):64.
PMID: 39462423 PMC: 11515105. DOI: 10.1186/s13005-024-00467-5.
Sun J, Kuai X, Huang D, Ji X, Jia C, Wang S Front Oncol. 2024; 14:1446736.
PMID: 39429473 PMC: 11486712. DOI: 10.3389/fonc.2024.1446736.
Performance of radiomics in the differential diagnosis of parotid tumors: a systematic review.
Rao Y, Ma Y, Wang J, Xiao W, Wu J, Shi L Front Oncol. 2024; 14:1383323.
PMID: 39119093 PMC: 11306159. DOI: 10.3389/fonc.2024.1383323.